Physician profile
Matthew Torres
NPI 1073928859
$1,800.67
in general payments reported to CMS, 2019-2025
10 companies · $43.52 in 2025
The $43.52 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.86 · 2020: $130 · 2021: $261 · 2022: $888 · 2023: $412 · 2024: $16.28 · 2025: $43.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $818.60 | 2020-2023 | Trumatch |
| Axogen | $525.19 | 2022 | |
| Nobel Biocare USA | $101.25 | 2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $88.55 | 2023 | Bio-Materials |
| Dentsply Sirona INC | $75.29 | 2021-2024 | Implant Dentistry, Astra Tech Implant System, Primescan Connect |
| Zimvie INC. | $69.43 | 2023 | |
| Medical Device Business Services, INC. | $49.86 | 2019 | |
| Ethicon US, LLC | $28.98 | 2022 | |
| Straumann USA LLC | $22.18 | 2025 | |
| Boston Scientific Corporation | $21.34 | 2025 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.